A
WST icon

AustralianSuper’s West Pharmaceutical WST Stock Holding History

AustralianSuper’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-273,241
Closed -$90M – 261
2024
Q2 		$90M Sell
273,241
-1,219
-0.4% -$431K 0.52% 60
2024
Q1 		$109M Sell
274,460
-47,828
-15% -$17.7M 0.64% 54
2023
Q4 		$113M Hold
322,288
– – 0.68% 46
2023
Q3 		$121M Buy
322,288
+2,517
+0.8% +$973K 0.78% 35
2023
Q2 		$122M Sell
319,771
-10,494
-3% -$3.75M 0.78% 35
2023
Q1 		$114M Sell
330,265
-562
-0.2% -$164K 0.7% 37
2022
Q4 		$77.5M Buy
+330,827
New +$78.4M 0.52% 55

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AustralianSuper's WST Position: Q3 2024 in Review

AustralianSuper sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 273,241 shares — an estimated $90M sold.

AustralianSuper first reported a position in WST in Q4 2022 and held it in 7 quarters. The position peaked at $122M in Q2 2023. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • AustralianSuper reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • AustralianSuper sold 273,241 West Pharmaceutical shares in Q3 2024, an estimated $90M.
  • AustralianSuper first reported a position in West Pharmaceutical in Q4 2022 and held it in 7 quarters.
  • AustralianSuper's West Pharmaceutical position peaked at $122M in Q2 2023.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on AustralianSuper's 13F filing for Q3 2024, filed 28 Oct 2024.